FindTrial
Sign In

TO STUDY THE EFFECT OF A DRUG CALLED PENTOXYFYLLINE ON THE BLOOD SUPPLY OF THE HIP JOINT

USE OF PENTOXYFYLLINE FOR TREATMENT OF AVASCULAR NECROSIS OF THE FEMORAL HEAD

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/05/025418
Enrollment
100
Registered
2020-05-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M169- Osteoarthritis of hip, unspecified

Interventions

Intervention1: Use of pentoxyfylline 400mg for the treatment of AVN of the femoral head: Tab Pentoxyfylline 400mg PO BD to be given to diagnosed cases of AVN of the femoral head Control Intervention1:

Sponsors

ELECTRICWALA HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of avascular necrosis of the femoral head

Exclusion criteria

Exclusion criteria: Pregnant and lactating mother Cardiovascular disease Allergy to pentoxyfylline

Design outcomes

Primary

MeasureTime frame
Progression of AVN on XRay and MRI as per Ficat Arlet classification Timepoint: 3 months, 6 months and 1 year—

Secondary

MeasureTime frame
Percentage of femoral head involvement on XRay and MRITimepoint: 3 months, 6 months and 1 year—

Countries

India

Contacts

Public ContactAli Electricwala

Electricwala Hospital, Pune

ali.electricwala@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026